| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acid suppressants reduce the therapeutic effect of immune checkpoint inhibitors and increase the risk of acute kidney injury: a meta-analysis
|
Okamoto, Keisuke
|
|
|
28 |
10 |
p. 1343-1353
|
artikel
|
| 2 |
Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022
|
Ishikura, Kenji
|
|
|
28 |
10 |
p. 1333-1342
|
artikel
|
| 3 |
Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
|
Muto, Satoru
|
|
|
28 |
10 |
p. 1259-1297
|
artikel
|
| 4 |
Chapter 2:indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
|
Nishiyama, Hiroyuki
|
|
|
28 |
10 |
p. 1298-1314
|
artikel
|
| 5 |
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
|
Ando, Yuichi
|
|
|
28 |
10 |
p. 1315-1332
|
artikel
|
| 6 |
Clinical significance of intraperitoneal paclitaxel combined with systemic chemotherapy for gastric cancer with peritoneal metastasis
|
Nakashima, Taiki
|
|
|
28 |
10 |
p. 1371-1377
|
artikel
|
| 7 |
Clinical significance of metastatic tumor deposit foci in rectal cancer in the lateral pelvic lymph node area
|
Yamai, Daisuke
|
|
|
28 |
10 |
p. 1388-1397
|
artikel
|
| 8 |
Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1
|
Nishio, Makoto
|
|
|
28 |
10 |
p. 1369-1370
|
artikel
|
| 9 |
Effects and risk factors of TAS-102 in real-world patients with metastatic colorectal cancer, EROTAS-R study
|
Yoshida, Naohisa
|
|
|
28 |
10 |
p. 1378-1387
|
artikel
|
| 10 |
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1
|
Nishio, Makoto
|
|
|
28 |
10 |
p. 1354-1368
|
artikel
|
| 11 |
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition
|
Mishima, Saori
|
|
|
28 |
10 |
p. 1237-1258
|
artikel
|
| 12 |
Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study
|
Baba, Tsukasa
|
|
|
28 |
10 |
p. 1411-1420
|
artikel
|
| 13 |
Retrospective study of the efficacy and safety of docetaxel/carboplatin combination therapy as postoperative adjuvant chemotherapy for nonsquamous cell carcinoma of the cervix
|
Koike, Ryo
|
|
|
28 |
10 |
p. 1421-1430
|
artikel
|
| 14 |
Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study
|
Nishiyama, Hiroyuki
|
|
|
28 |
10 |
p. 1398-1410
|
artikel
|
Tijdschrift beschrijving